BioNano Genomics and New York Genome Center Enter Into a Strategic Collaboration
July 8, 2013
SAN DIEGO and NEW YORK, -- BioNano Genomics and the New York Genome Center (NYGC) announced today a strategic partnership between the two institutions that includes the purchase of an Irys™ System by NYGC. "The New York Genome Center is creating one of the largest and most ambitious genomics and bioinformatics facilities in North America, [...]
July 8, 2013
MICKLETON, N.J.-- Saint-Gobain Performance Plastics (SGPPL) introduces Chromatography Assemblies for GC and HPLC autosamplers. Each assembly includes a choice of clear 2mL 33-Expansion (33E) or 51-Expansion (51E) borosilicate glass vials plus cap and liner closures, manufactured exclusively to provide a perfect fit on the vials. Closures are made from ultra-pure and chemically resistant materials to [...]
July 8, 2013
Analyze IQ Limited, producers of the world’s most advanced spectroscopy analysis software, has today announced the release of Analyze IQ SmartSearch, the latest addition to their Analyze IQ Software Suite. Analyze IQ SmartSearch allows you to search rapidly and accurately through a library of spectra, to identify the best matches for unknown spectra, enabling you [...]
Leica Biosystems Acquires Kreatech Diagnostics
July 8, 2013
Leica Biosystems announced that it has acquired Kreatech Diagnostics, a privately-held provider of DNA fluorescent in-situ hybridization (FISH) probes and target labeling reagents for microarrays. "We are very pleased with the acquisition of Kreatech, its extensive portfolio and development expertise. This will allow Leica Biosystems to better serve our cytogenetics and anatomic pathology customers. It [...]
Cell Metric CLDTM success in US biopharma for single cell cloning
July 8, 2013
Bournemouth, UK – Due to the significant time saving advantages of their Cell MetricTM systems, Solentim, the market-leading developer of innovative tools for shortening steps in the upstream cell line development workflow, have had their best quarter of sales revenues to date. This includes multiple shipments of Cell MetricTM systems to customers in the US [...]
Kewaunee Scientific Announces Buyout of its International Operations Minority Shares
July 8, 2013
STATESVILLE, N.C., -- Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announced that it had acquired all of the outstanding minority shares of its subsidiary in Singapore, Kewaunee Labway Asia Pte. Ltd. Through its headquarters in Singapore and its subsidiary [...]
Xylem’s YSI product selected for prestigious Editor’s Choice Award
July 8, 2013
WHITE PLAINS, N.Y.-- Xylem Inc. (NYSE: XYL), a leading global water technology company focused on addressing the world’s most challenging water issues, announced today that its YSI brand NiCaVis® 700 Series IQ Sensor has been selected by Pollution Engineering magazine as an Editor’s Choice Award winner for 2013. The NiCaVis Sensor, used with the IQ [...]
BD Appoints Christopher Reidy as Chief Financial Officer
July 8, 2013
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the appointment of Christopher Reidy as Chief Financial Officer and Executive Vice President of Administration, effective July 15, 2013. Mr. Reidy will report to Vincent A. Forlenza, Chairman, Chief Executive Officer and President. Mr. Reidy, 55, will [...]
New MuPac Offers Measurement of Uncertainty for Titration
July 4, 2013
Schwerzenbach, Switzerland –- METTLER TOLEDO offers a new and unique service to titration customers, the Measurement Uncertainty Pac (MuPac), part of the Good Titration PracticeTMSecure service offerings. MuPac offers a detailed calculation of a titration method’s result uncertainty accounting for all processes involved in the titration and sample preparation. This enables users to comply with [...]
July 4, 2013
UCART19 is a revolutionary engineered T-cell product that leverages Cellectis’ core technologies in genome engineering. This standardized “off-the-shelf” therapy product is designed with a “chimeric antigen receptor” (CAR) to target and kill the most common types of acute and chronic leukemia and are engineered with Cellectis’ nucleases enabling the use of non-patient derived (allogeneic) T-cells. [...]

